Skip to main content
. 2022 May 13;5:100157. doi: 10.1016/j.jtauto.2022.100157

Table 4.

Correlations between RDW, NLR and PLR and clinical parameters.

RDW
NLR
PLR
R p r p r p
Disease duration (years) 0.143 0.213 0.247 0.030 0.181 0.114
SLEDAI-2K 0.288 0.012 0.111 0.343 0.183 0.116
SLICC/ACR 0.235 0.039 0.017 0.881 −0.072 0.531
C3 complement (mg/dl) −0.165 0.153 −0.249 0.019 −0.324 0.004
C4 complement (mg/dl) 0.055 0.637 −0.150 0.194 −0.140 0.224
ESR (mm/h) 0.041 0.732 0.094 0.436 0.039 0.746
hsCRP (mg/l) 0.258 0.026 0.094 0.426 −0.154 0.190
Fibrinogen (mg/dl) 0.255 0.025 −0.022 0.852 0.051 0.659
Homocysteine (μmol/L) 0.193 0.097 0.061 0.605 0.016 0.890
Ddimer (0.23 μg/ml) 0.238 0.039 0.160 0.166 0.161 0.164
Creatinine (mg/dl) 0.117 0.312 −0.080 0.489 −0.181 0.115
Creatinine clearance (Cockcroft) −0.131 0.262 0.060 0.612 −0.009 0.940
IL-6 (pg/ml) 0.325 0.012 0.101 0.445 0.065 0.624
IL-10 (pg/ml) 0.119 0.368 0.065 0.624 −0.101 0.445
TNF (pg/ml) 0.260 0.047 0.036 0.787 0.091 0.543
IFNγ (pg/ml) 0.128 0.342 0.007 0.959 0.247 0.064

RDW: Red blood cell distribution width, NLR: Neutrophil-to-lymphocyte ratio, PLR: Platelet-to-lymphocyte ratio, SLEDAI: SLE Disease Activity Index, SLICC/ACR: Systemic Lupus International Collaborative Clinics/American College of Rheumatology, ESR: Erythrocyte sedimentation rate, hsCRP: High-sensitive C-reactive protein, TNF: Tumor necrosis factor, IFNγ: Interferon γ